Literature DB >> 28477413

Emergency treatment of hypoglycaemia: a guideline and evidence review.

M Villani1, B de Courten1,2, S Zoungas1,2,3.   

Abstract

AIM: To examine the current treatment guidelines for the emergency management of hypoglycaemia and the evidence underpinning recommendations.
METHODS: International diabetes agencies were searched for hypoglycaemia treatment guidelines. Guidelines were assessed using the Appraisal of Guidelines Research and Evaluation II (AGREE II) instrument. An electronic database search was conducted for evidence regarding emergency treatment of hypoglycaemia in adults, and relevant articles were critically appraised.
RESULTS: Of the international diabetes agencies, six sets of guidelines were deemed relevant and of sufficient detail for appraisal by AGREE II. The evidence search returned 2649 articles, of which 17 pertaining to the emergency management of hypoglycaemia were included. High-quality evidence for the management of hypoglycaemia was lacking, limiting treatment recommendations. In general, guidelines and studies were somewhat concordant and recommended 15-20 g of oral glucose or sucrose, repeated after 10-15 min for treatment of the responsive adult, and 10% intravenous dextrose or 1 mg intramuscular glucagon for treatment of the unresponsive adult. No evidence was found for other treatment approaches.
CONCLUSION: Evidence for the emergency treatment of hypoglycaemia in adults is limited, is often low grade and mostly pre-dates contemporary management of diabetes. Guideline recommendations are limited by the lack of randomized trials. Further high-quality studies are required to inform the optimum management of this frequently occurring emergency condition.
© 2017 Diabetes UK.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28477413     DOI: 10.1111/dme.13379

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  4 in total

1.  Nasal Glucagon Versus Injectable Glucagon for Severe Hypoglycemia: A Cost-Offset and Budget Impact Analysis.

Authors:  Johannes Pöhlmann; Beth D Mitchell; Sanjay Bajpai; Beatrice Osumili; William J Valentine
Journal:  J Diabetes Sci Technol       Date:  2019-01-30

2.  Predictive Low-Glucose Suspend Necessitates Less Carbohydrate Supplementation to Rescue Hypoglycemia: Need to Revisit Current Hypoglycemia Treatment Guidelines.

Authors:  Jordan E Pinsker; Amy Bartee; Michelle Katz; Amy Lalonde; Richard Jones; Eyal Dassau; Howard Wolpert
Journal:  Diabetes Technol Ther       Date:  2021-02-18       Impact factor: 6.118

3.  Usability of Nasal Glucagon Device: Partially Randomized Caregiver and Third-Party User Experience Trial with Simulated Administration at a Japanese Site.

Authors:  Toshihiko Aranishi; Yukiko Nagai; Yasushi Takita; Shuyu Zhang; Rimei Nishimura
Journal:  Diabetes Ther       Date:  2019-11-04       Impact factor: 2.945

4.  Ambient Particulate Matter and Paramedic Assessments of Acute Diabetic, Cardiovascular, and Respiratory Conditions.

Authors:  Fay H Johnston; Farhad Salimi; Grant J Williamson; Sarah B Henderson; Jiayun Yao; Martine Dennekamp; Karen Smith; Michael J Abramson; Geoffrey G Morgan
Journal:  Epidemiology       Date:  2019-01       Impact factor: 4.822

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.